Try Autologous Exosomes instead of PRP using Exosmart
Exosmart is plasma derived from human blood using an ultrafiltration process.
This medical device concentrates platelet-derived components to support and stimulate tissue repair.
Autologous Exosomes via Ultrafiltration
Ultrafiltration technology enhances the release of exosomes by applying mechanical stimulation to platelets.
Multiple studies have reported this method as effective in increasing both purity and concentration during the purification process.
Why Choose Exosomes Over PRP?
Platelet-derived exosomes offer greater stability and lower immunogenicity compared to traditional PRP.
They play a critical role in intercellular communication and tissue regeneration.
Exosomes are increasingly recognised as key mediators responsible for many of the physiological effects associated with PRP.
Exosmart™ is a CE-MDR certified Class IIa medical device advancing regenerative medicine through its patented ultrafiltration technology. Featuring a 15 kDa molecular weight cut-off membrane, Exosmart™ processes 30 mL of plasma (derived from 60 mL of blood) into 6–7 mL of highly concentrated therapeutic solution containing up to 30 trillion exosomes per millilitre—up to 136 times higher than standard reference levels.
Validated in line with MISEV2023 guidelines, the system demonstrates outstanding purity, including 93.2% CD9-positive markers and a 47% increase in PDGF-bb growth factor concentration. The final product contains exosomes (30–150 nm), platelets (70–95% recovery rate), key growth factors (VEGF, TGF-β, FGF), cytokines, and plasma proteins. Together, these components work synergistically to regulate inflammation, activate stem cells, enhance angiogenesis, and accelerate tissue repair across a wide range of clinical indications.
With a strong safety profile—reporting zero adverse events in clinical evaluations—and a 100% processing success rate, Exosmart™ elevates routine treatments into advanced regenerative therapies. From orthopaedics and aesthetics to wound management and surgical use, it delivers consistent, standardised outcomes that can often be achieved in a single session compared to the multiple treatments required by conventional approaches.